Journal for ImmunoTherapy of Cancer (Nov 2020)
861 Development of FPA157, an anti-CCR8 depleting antibody engineered to preferentially eliminate tumor-infiltrating T regulatory cells
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2020)